Compare GTY & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GTY | TNDM |
|---|---|---|
| Founded | 1955 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 1998 | 2013 |
| Metric | GTY | TNDM |
|---|---|---|
| Price | $33.91 | $24.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 18 |
| Target Price | ★ $32.20 | $27.89 |
| AVG Volume (30 Days) | 671.7K | ★ 2.5M |
| Earning Date | 05-14-2026 | 05-19-2026 |
| Dividend Yield | ★ 5.74% | N/A |
| EPS Growth | ★ 8.00 | N/A |
| EPS | ★ 1.35 | N/A |
| Revenue | $221,727,000.00 | ★ $1,014,736,000.00 |
| Revenue This Year | $8.72 | $8.01 |
| Revenue Next Year | $7.81 | $12.14 |
| P/E Ratio | $25.13 | ★ N/A |
| Revenue Growth | ★ 9.02 | 7.93 |
| 52 Week Low | $25.39 | $10.00 |
| 52 Week High | $34.02 | $29.65 |
| Indicator | GTY | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 69.12 | 58.99 |
| Support Level | $26.74 | $19.66 |
| Resistance Level | N/A | $29.65 |
| Average True Range (ATR) | 0.59 | 1.20 |
| MACD | -0.04 | -0.14 |
| Stochastic Oscillator | 99.08 | 63.19 |
Getty Realty Corp is the real estate investment trust in the U.S. specializing in the acquisition, financing, and development of convenience, automotive, and other single tenant retail real estate. The company's portfolio includes convenience stores, car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, collision), automotive parts retailers, and certain other freestanding retail properties, including drive-thru quick service restaurants. It generates majority of the revenue in the form of rental income.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.